The Pursuit of Optimal Outcomes in Cancer Therapy in a New Age of Rationally Designed Target-Based Anticancer Agents
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 60 (1) , 1-14
- https://doi.org/10.2165/00003495-200060001-00001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cellsOncogene, 1998
- Epidermal Growth Factor Receptor Family and ChemosensitizationJNCI Journal of the National Cancer Institute, 1997
- The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate CarcinomaJournal of Immunotherapy, 1996
- New Molecular Targets for Cancer TherapyScientific American, 1996
- Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in VitroJournal of Biological Chemistry, 1995
- Pharmaceutical research in molecular oncologyCell, 1994
- Randomized discontinuation trials: Utility and efficiencyJournal of Clinical Epidemiology, 1993
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993
- Patient noncompliance with self-administered chemotherapyCancer, 1990